Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism
To identify interactions a nucleoside analog library (NAL) consisting of 45 FDA-approved nucleoside analogs was screened against 23 enzymes of the human nucleotide metabolism using a thermal shift assay. The method was validated with deoxycytidine kinase; eight interactions known from the literature...
Saved in:
Main Authors: | Egeblad, Louise, Welin, Martin, Flodin, Susanne, Gräslund, Susanne, Wang, Liya, Balzarini, Jan, Eriksson, Staffan, Nordlund, Pär |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2013
|
Online Access: | https://hdl.handle.net/10356/95769 http://hdl.handle.net/10220/9364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
by: Surachet Niruntraporn, et al.
Published: (2018) -
Anti-ageing effects of FDA-approved medicines: a focused review
by: Thanapairoje K.
Published: (2023) -
rFC- the FDA approved endotoxin test: Discovery, Innovations & Applications
by: Ding, Jeak Ling
Published: (2021) -
Inducing compliance with postmarket studies for drugs under FDA's accelerated approval pathway
by: XU, Liang, et al.
Published: (2021) -
Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
by: Loe, MWC, et al.
Published: (2020)